Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Biotech components
Biotech components
Molecule
Products 11 to 20 of 38
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Endocannabinoids for intestinal infection treatment
by
University of Texas Southwestern Medical Center
Biotech components:
Molecule
+
Plant
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (2 years ago)
Date last modified:
2020/12/18 14:39 (2 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
N/A
fiberTyping
by
Applied DNA Sciences
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2019/01/30 11:57 (4 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Security
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Forensic Tagging
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Finished Product
Gene-edited Produce
by
Pairwise Plants
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/10/08 14:49 (4 years ago)
Known funding amount:
125,000,000 USD
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Plant
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
implanted device to control bladder function
by
Biotech components:
Animal
+
Molecule
Business models:
N/A
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/04/01 10:01 (4 years ago)
Date last modified:
2019/04/12 09:36 (4 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Medical
Market status:
Under Development
+
More information needed
Organization type(s):
N/A
Product categories:
N/A
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
PCR-produced linear DNA
by
Applied DNA Sciences
+
LineaRx
Biotech components:
Molecule
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
+
Government
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2019/01/30 11:54 (4 years ago)
Known funding amount:
19,800,000 USD
Funding types:
Shareholder Investment
Industry:
Science
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Research
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
APDN
(NASDAQ)
Value chain stage:
Platform
Mast-MO (antibiotic wasp venom)
by
University of Pennsylvania’s Perelman School of Medicine
Biotech components:
Animal
+
Bacteria
+
Molecule
Business models:
B2B
+
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:40 (2 years ago)
Date last modified:
2020/12/18 14:40 (2 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
MG53 (natural human protein) (preventing lethal lung damage from the flu)
by
Ohio State University
Biotech components:
Molecule
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (2 years ago)
Date last modified:
2020/12/18 14:39 (2 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medicine
+
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
N/A
Myristoyl Glutamate (Surfactant)
by
Modular Genetics, Inc.
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/08/30 11:49 (4 years ago)
Known funding amount:
1,121,998 USD
Funding types:
Private Funding
+
University
+
Government
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
NanoHeal
by
RISE PFI AS
Biotech components:
Molecule
Business models:
B2B
Country of production:
Norway
Country of distribution:
Norway
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (4 years ago)
Date last modified:
2018/10/08 14:51 (4 years ago)
Known funding amount:
N/A
Funding types:
Government
+
University
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
OG716: Lantibiotics
by
Oakbio
+
Oragenics
Biotech components:
Molecule
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:12 (3 years ago)
Date last modified:
2019/09/12 15:16 (3 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
Shareholder Investment
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Medicine
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
1
2
3
4
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
